We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+8.94%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$76.2B
AUM Growth
+$2.6B
(+3.5%)
Cap. Flow
-$2.97B
Cap. Flow
% of AUM
-3.9%
Top 10 Holdings %
Top 10 Hldgs %
21.61%
Holding
3,238
New
235
Increased
684
Reduced
2,065
Closed
243
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$77.3M |
| 2 |
Blackstone
BX
|
+$53.2M |
| 3 |
NXP Semiconductors
NXPI
|
+$40.8M |
| 4 |
Palantir
PLTR
|
+$34.3M |
| 5 |
Snowflake
SNOW
|
+$24.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$206M |
| 2 |
Microsoft
MSFT
|
+$163M |
| 3 |
Linde
LIN
|
+$133M |
| 4 |
Amazon
AMZN
|
+$94.7M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$82.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.34% |
| 2 | Financials | 14.16% |
| 3 | Healthcare | 12.95% |
| 4 | Consumer Discretionary | 12.06% |
| 5 | Communication Services | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Array Technologies
ARRY
$847M
| $2.57M | ﹤0.01% |
164,519
+80,661
| +96% | +$1.7M |
|
|
EBIX
1827
DELISTED
Ebix Inc
EBIX
| $2.56M | ﹤0.01% |
75,643
+2,719
| +4% | +$84.2K |
|
1828
Coherus Oncology
CHRS
$205M
| $2.56M | ﹤0.01% |
185,349
-2,818
| -1% | -$39.9K |
|
|
EFC
1829
Ellington Financial
EFC
$1.69B
| $2.56M | ﹤0.01% |
133,742
+73,414
| +122% | +$1.36M |
|
1830
Unitil
UTL
$971M
| $2.55M | ﹤0.01% |
48,100
+23,537
| +96% | +$1.27M |
|
|
HTLF
1831
DELISTED
Heartland Financial USA, Inc.
HTLF
| $2.54M | ﹤0.01% |
54,061
+2,473
| +5% | +$123K |
|
1832
Revolve Group
RVLV
$1.79B
| $2.54M | ﹤0.01% |
+36,814
| New | +$1.98M |
|
1833
GrowGeneration
GRWG
$90.1M
| $2.54M | ﹤0.01% |
52,695
+12,495
| +31% | +$547K |
|
|
KRTX
1834
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $2.52M | ﹤0.01% |
22,111
+3,756
| +20% | +$439K |
|
1835
CarGurus
CARG
$3.49B
| $2.51M | ﹤0.01% |
95,659
+1,811
| +2% | +$47K |
|
|
AGR
1836
DELISTED
Avangrid, Inc.
AGR
| $2.51M | ﹤0.01% |
48,736
-1,678
| -3% | -$87.5K |
|
1837
America's Car Mart
CRMT
$27.6M
| $2.5M | ﹤0.01% |
17,620
-906
| -5% | -$136K |
|
|
NFBK
1838
DELISTED
Northfield Bancorp
NFBK
| $2.5M | ﹤0.01% |
152,202
-10,081
| -6% | -$166K |
|
1839
Kadant
KAI
$3.98B
| $2.49M | ﹤0.01% |
14,159
-1,004
| -7% | -$177K |
|
1840
Central Pacific Financial
CPF
$1.01B
| $2.49M | ﹤0.01% |
95,414
-4,671
| -5% | -$128K |
|
1841
Revolution Medicines
RVMD
$43.1B
| $2.48M | ﹤0.01% |
78,201
+32,407
| +71% | +$1.13M |
|
|
CLR
1842
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $2.47M | ﹤0.01% |
64,927
-13,694
| -17% | -$426K |
|
1843
Cimpress
CMPR
$2.39B
| $2.46M | ﹤0.01% |
22,673
-7,829
| -26% | -$791K |
|
|
AGNT
1844
AGNT Inc
AGNT
$705M
| $2.46M | ﹤0.01% |
63,358
+8,747
| +16% | +$301K |
|
|
RVNC
1845
DELISTED
Revance Therapeutics, Inc.
RVNC
| $2.44M | ﹤0.01% |
82,463
-5,866
| -7% | -$169K |
|
1846
QuinStreet
QNST
$1.16B
| $2.44M | ﹤0.01% |
131,487
-18,941
| -13% | -$359K |
|
|
HOME
1847
DELISTED
At Home Group Inc.
HOME
| $2.44M | ﹤0.01% |
66,312
-20,923
| -24% | -$713K |
|
1848
Nelnet
NNI
$4.6B
| $2.44M | ﹤0.01% |
32,460
-3,130
| -9% | -$235K |
|
1849
Opko Health
OPK
$1B
| $2.44M | ﹤0.01% |
602,655
-72,671
| -11% | -$285K |
|
1850
Sphere Entertainment
SPHR
$5.62B
| $2.44M | ﹤0.01% |
29,067
+7,068
| +32% | +$626K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2021 Portfolio in Review
As of Q2 2021, RhumbLine Advisers held 3,238 positions worth $76.2B, up 3.5% from $73.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
RhumbLine Advisers withdrew a net $2.97B in Q2 2021, closing 243 positions and reducing 2,065 holdings. Its most notable exit was Varian Medical Systems, Inc., an estimated $32.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
Against the trend, RhumbLine Advisers opened a new position in DraftKings worth $14.2M.
- RhumbLine Advisers's largest Q2 2021 buy was DraftKings: 271,227 shares worth $14.2M.
- RhumbLine Advisers added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $77.3M increase.
- RhumbLine Advisers's biggest Q2 2021 reduction was Apple, cutting an estimated $206M.
- RhumbLine Advisers fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $32.1M.
- RhumbLine Advisers's ten largest holdings make up 22% of its $76.2B portfolio in Q2 2021.
- RhumbLine Advisers opened 235 new positions and closed 243 in Q2 2021.
- RhumbLine Advisers's portfolio value rose 3.5% quarter-over-quarter to $76.2B.
Based on RhumbLine Advisers's 13F filing for Q2 2021, filed 5 Aug 2021.